PARP Inhibitor Tolerability and Impact on Progression-Free Survival in Patients with High-Grade, Ovarian Carcinoma with Brain Metastasis: A Case-Series

Alexander Mohler; Belkys Salinas; Nicholas Lambrou; Karissa Nazur; Yazmin Odia; Rupesh Kotecha

PARP Inhibitor Tolerability and Impact on Progression-Free Survival in Patients with High-Grade, Ovarian Carcinoma with Brain Metastasis: A Case-Series

Alexander Mohler
, Belkys Salinas
, Nicholas Lambrou
, Karissa Nazur
, Yazmin Odia
, Rupesh Kotecha

Miami Cancer Institute

Research output: Contribution to conference › Presentation

Original language	American English
State	Published - Aug 19 2021

Access to Document

ViewcontentFinal published version, 20.4 KBLicense: Unspecified

Cite this

@conference{c7b42bfbd1c24587807743a2782f23a0,

title = "PARP Inhibitor Tolerability and Impact on Progression-Free Survival in Patients with High-Grade, Ovarian Carcinoma with Brain Metastasis: A Case-Series",

author = "Alexander Mohler and Belkys Salinas and Nicholas Lambrou and Karissa Nazur and Yazmin Odia and Rupesh Kotecha",

year = "2021",

month = aug,

day = "19",

language = "American English",

}

TY - CONF

T1 - PARP Inhibitor Tolerability and Impact on Progression-Free Survival in Patients with High-Grade, Ovarian Carcinoma with Brain Metastasis: A Case-Series

AU - Mohler, Alexander

AU - Salinas, Belkys

AU - Lambrou, Nicholas

AU - Nazur, Karissa

AU - Odia, Yazmin

AU - Kotecha, Rupesh

PY - 2021/8/19

Y1 - 2021/8/19

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/4049

M3 - Presentation

ER -

PARP Inhibitor Tolerability and Impact on Progression-Free Survival in Patients with High-Grade, Ovarian Carcinoma with Brain Metastasis: A Case-Series

Access to Document

Other files and links

Cite this